AASANDHA SCHEME
Master Medicine and Consumable list as at 14th May 2026
test
| Code | mfda_code | Generic | Product name | Strength | Volume | Preparation | Master Price (MVR) |
|---|---|---|---|---|---|---|---|
| M3165 | P3455 | Levofloxacin | Levoxin | 250 mg | Tablet | 4.08 | |
| M3166 | P3656 | Levofloxacin | Levocil | 250 mg | Tablet | 2.85 | |
| M3167 | P3662 | Levofloxacin | Levocil | 500 mg | Tablet | 4.96 | |
| M3652 | P4716 | Levofloxacin | Levocin | 500 mg | Tablet | 4.79 | |
| M3908 | P7189 | Levofloxacin | Resquin | 500 mg | Tablet | 4.56 | |
| M3946 | P7205 | Levofloxacin | Levcin 500 | 500 mg | Tablet | 3.19 | |
| TM0623 | P3917 | Levosalbutamol | Levosalbutamol | 100 mcg per md | Inhaler | 183.6 | |
| TM0624 | P3916 | Levosalbutamol | Levosalbutamol | 50 mcg per md | Inhaler | 127.5 | |
| M3134 | P0270 | Levosalbutamol Sulphate + Guaiphenesin | Asthalin Expectorant | 0.5mg + 50 mg in 5 ml | 100ml | Oral Liquid | 23.46 |
| TM0399 | P3353 | Levosulpride | Levosulpiride | 25 mg | Tablet | 4.85 | |
| M1519 | P2628 | Levothyroxine Sodium | T4 Montpellier | 100 mcg | Tablet | 1.02 | |
| M3848 | P3051 | Levothyroxine Sodium | Thyrox 25 | 25 mcg | Tablet | 0.97 | |
| M3849 | P3050 | Levothyroxine Sodium | Thyrox 50 | 50 mcg | Tablet | 0.97 | |
| M3850 | P4394 | Levothyroxine Sodium | Thyrox 75 | 75 mcg | Tablet | 1.46 | |
| M3851 | P6817 | Levothyroxine Sodium | Thyrox 100 | 100 mcg | Tablet | 1.46 | |
| TM0176 | P3050 | Levothyroxine Sodium | Levothyroxine Sodium | 50 mcg | Tablet | 1.02 | |
| TM0177 | P3051 | Levothyroxine Sodium | Levothyroxine Sodium | 25 mcg | Tablet | 1.02 | |
| M3876 | P5955 | Lidocaine Hydrochloride | Xylogel 2% | 20 mg | 30 g | Gel (Topical) | 16.84 |
| M3774 | P5102 | Lidocaine Hydrochloride + Sodium Chloride +Methylparaben + Water for Injection | Anasica 2% | (21.33 mg+ 6.00mg+ 1.00mg + 1.0 ml)/ ml | 30 ml | Injection | 15.46 |
| M1528 | P2261 | Lignocaine | Anasica Jelly | 0.02 | Gel | 25.5 |